Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
Main Filters
Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
| AUTOGENOMICS, INC | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 01-1020-01 | 0 | - | ||
| 01-1050-01 | 0 | - | ||
| 01-2020-01 | 0 | - | ||
| 01-2050-01 | 0 | - | ||
| 01-3020-01 | 0 | - | ||
| 01-3050-01 | 0 | - | ||
| CEPHEID | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| GXFIIFV-10 | 0 | - | ||
| GXHEMOSIL-10 | 0 | - | ||
| Hologic, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 95-453 | 0 | - | ||
| 95-457 | 0 | - | ||
| LUMINEX CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 20-006-001 | 0 | - | ||
| 30-001-001 | 0 | - | ||
| NANOSPHERE, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 20-006-001 | 0 | - | ||
| 30-001-001 | 0 | - | ||
| Roche Diagnostics GmbH | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 04618955001 | 0 | - | ||
| Roche Molecular Systems, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 07948352190 | 0 | - | ||
16 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Hypercoagulation Panel (HC) Sample Buffer
NANOSPHERE, INC.
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
0
-
Hypercoagulation Panel (HC) Nucleic Acid Test Cartridge
NANOSPHERE, INC.
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
0
-
INFINITI® Factor II-V Leiden Amplification Mix
AUTOGENOMICS, INC
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
0
-
INFINITI® Factor II-V Leiden Intellipac® Reagent Module
AUTOGENOMICS, INC
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
0
-
INFINITI® Factor II-V Leiden BioFilmChip® Microarray Magazine
AUTOGENOMICS, INC
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
0
-
INFINITI® Factor II Amplification Mix
AUTOGENOMICS, INC
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutations.
0
-
INFINITI® Factor II Intellipac® Reagent Module
AUTOGENOMICS, INC
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutation
0
-
INFINITI® Factor II BioFilmChip® Microarray Magazine
AUTOGENOMICS, INC
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutations.
0
-
Hypercoagulation Panel (HC) Sample Buffer
LUMINEX CORPORATION
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
0
-
Hypercoagulation Panel (HC) Nucleic Acid Test Cartridge
LUMINEX CORPORATION
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.